Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MIMEDX GRP INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Net Sales248.23299.26359.11321.14221.71187.30118.2259.1827.057.76
Grant revenue--------------------
Total Revenues248.23299.26359.11321.14221.71187.30118.2259.1827.057.76
Cost of sales39.3343.0836.3935.2230.9420.2012.679.335.193.36
Gross Margin208.90256.17322.73285.92190.77167.09105.5649.8521.874.40
Amortization of intangible assets1.071.041.031.682.140.930.931.051.381.34
Research and development expenses11.7211.1415.7717.9014.348.417.054.842.892.98
Acquired in-process research and development--------------------
Selling, general and administrative expenses181.02198.21258.53220.12173.41133.3890.4846.2319.599.85
Impairment of intangible assets(1.03)(0.45)--0.00------(0.37)(1.80)--
Gain on sale of assets--------------------
Fair value adjustment of earn-out liability----------------(1.57)(0.01)
Investigation, restatement and related(59.47)(66.50)(51.32)--------------
Operating Income (Loss)(45.40)(21.16)(3.92)46.220.8824.367.10(2.64)(5.36)(9.76)
Interest expense, net----------0.090.05--0.590.12
Change in fair value of investment, related party--------------------
Interest (expense) income, net(7.94)(4.71)0.53(0.09)------(0.05)----
Other income (expense), net0.000.28----(0.34)----------
Amortization of debt discount--------------(1.33)(1.71)(0.32)
Gain on divestiture------(1.05)------------
Financing expense associated with warrants issued in connection with convertible promissory note--------------------
Financing expense associated with issuance of common stock for registration rights waivers--------------------
Loss on extinguishment of debt(8.20)------------------
Income (loss) before income tax provision(61.54)(25.59)(3.40)45.090.5524.287.05(4.01)(7.66)(10.19)
Income tax (benefit) provision(12.26)(0.01)26.58(19.64)0.16(5.17)0.830.10----
Net Loss(49.28)(25.58)(29.98)64.73------(4.11)----
Accretion of redeemable common stock and common stock with registration rights to fair value--------------------
Net Income (Loss) Available to Common Shareholders(49.28)(25.58)(29.98)64.730.3929.456.22(4.11)(7.66)(10.19)
Net Earnings Per Share (Basic)(0.77)(0.24)(0.28)0.610.000.280.06(0.04)(0.09)(0.14)
Net Earnings Per Share (Diluted)(0.77)(0.24)(0.28)0.560.000.260.05(0.04)(0.09)(0.14)
Weighted Average Shares Outstanding (Basic)108.26106.95105.60106.12105.93105.93105.7996.2981.6572.45
Weighted Average Shares Outstanding (Diluted)108.26106.95105.60116.11112.65113.63113.3096.2981.6572.45